DIN/PIN Detail - 02434318

920000   MISCELLANEOUS THERAPEUTIC AGENTS
923600   DISEASE-MODIFYING ANTIRHEUMATIC AGENTS

OTEZLA (STARTER PACK) 10 MG * 20 MG * 30 MG ORAL TABLET

(APREMILAST/ APREMILAST/ APREMILAST)

Manufacturer:
CELGENE INC
ECDET Review Status/Past Decision(s):
N/A
CDR Status/Past Decision(s):

 CDR - List with clinical criteria and/or conditions


 CDR - List with criteria/condition


 2015/11/01 - Not a Benefit


 CDR - Do not list


To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.